NEW YORK (TheStreet) -- Merck
(MRK - Get Report) stock is gaining Tuesday after the pharmaceuticals company reported higher profits in its first quarter.
By early afternoon, shares were up 3% to $58.36.
The second-largest drugmaker in the U.S. earned an adjusted 88 cents a share, 9 cents higher than analysts polled by Thomson Reuters expected. Profitability was boosted over the quarter after research spending was cut 20 PERCENT to $1.5 billion.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
However, total sales fell 4% to $10.26 billion, missing analyst forecasts by around $177 million. Results on the top line suffered from increased competition from generic brands particularly for its allergy and asthma treatments.
Must Read: Warren Buffett's 10 Favorite Growth Stocks
STOCKS TO BUY: TheStreet's Stocks Under $10 has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
WATCH: More market update videos on TheStreet TV
| More videos from Keris Alison Lahiff
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts